BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 11316560)

  • 1. Treatment of keloids by high-dose-rate brachytherapy: A seven-year study.
    Guix B; Henríquez I; Andrés A; Finestres F; Tello JI; Martínez A
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):167-72. PubMed ID: 11316560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and the toxicity of the interstitial high-dose-rate brachytherapy in the management of recurrent keloids: 5-year outcomes.
    Jiang P; Geenen M; Siebert FA; Bertolini J; Poppe B; Luetzen U; Dunst J; Druecke D
    Brachytherapy; 2018; 17(3):597-600. PubMed ID: 29305151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative management of keloids: low-dose-rate and high-dose-rate brachytherapy.
    De Cicco L; Vischioni B; Vavassori A; Gherardi F; Jereczek-Fossa BA; Lazzari R; Cattani F; Comi S; De Lorenzi F; Martella S; Orecchia R
    Brachytherapy; 2014; 13(5):508-13. PubMed ID: 24556345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative Interstitial High-Dose-Rate Brachytherapy for the Treatment of Recurrent Keloids: Feasibility and Early Results.
    Jiang P; Baumann R; Dunst J; Geenen M; Siebert FA; Niehoff P; Bertolini J; Druecke D
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):532-6. PubMed ID: 26867882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-keloidectomy irradiation using high-dose-rate superficial brachytherapy.
    Kuribayashi S; Miyashita T; Ozawa Y; Iwano M; Ogawa R; Akaishi S; Dohi T; Hyakusoku H; Kumita S
    J Radiat Res; 2011; 52(3):365-8. PubMed ID: 21490411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative high-dose-rate brachytherapy in the prevention of keloids.
    Veen RE; Kal HB
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1205-8. PubMed ID: 17967309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Excision and Adjuvant Brachytherapy vs External Beam Radiation for the Effective Treatment of Keloids: 10-Year Institutional Retrospective Analysis.
    Hoang D; Reznik R; Orgel M; Li Q; Mirhadi A; Kulber DA
    Aesthet Surg J; 2017 Feb; 37(2):212-225. PubMed ID: 27553611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
    Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose-rate interstitial brachytherapy vs external beam radiation for the treatment of complex keloids.
    Liao Y; Dorafshar AH; Bernard D; Kim T; Camden NB; Wang D
    Med Dosim; 2022 Summer; 47(2):158-160. PubMed ID: 35264302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose-rate brachytherapy for the treatment of recalcitrant keloids: a unique, effective treatment protocol.
    van Leeuwen MCE; Stokmans SC; Bulstra AJ; Meijer OWM; van Leeuwen PAM; Niessen FB
    Plast Reconstr Surg; 2014 Sep; 134(3):527-534. PubMed ID: 25158710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perioperative interstitial brachytherapy for recurrent keloid scars].
    Rio E; Bardet E; Peuvrel P; Martinet L; Perrot P; Baraer F; Loirat Y; Sartre JY; Malard O; Ferron C; Dreno B
    Cancer Radiother; 2010 Jan; 14(1):65-8. PubMed ID: 19695929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative interstitial high-dose-rate brachytherapy for keloids scar.
    Barragán VV; García AIA; García JF; Marín MJ; Vivas JDCP; Rijo GJ
    J Contemp Brachytherapy; 2022 Feb; 14(1):29-34. PubMed ID: 35233232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer.
    Wazer DE; Berle L; Graham R; Chung M; Rothschild J; Graves T; Cady B; Ulin K; Ruthazer R; DiPetrillo TA
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):889-97. PubMed ID: 12095554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative strontium-90 brachytherapy in the prevention of keloids: results and prognostic factors.
    Viani GA; Stefano EJ; Afonso SL; De Fendi LI
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1510-6. PubMed ID: 19101094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface brachytherapy in the treatment of keloid scars in Mexico.
    Bautista Hernandez Y; Villavicencio Queijero MA; Quezada Bautista AA; Vazquez Tinajero A
    Rep Pract Oncol Radiother; 2020; 25(1):133-138. PubMed ID: 31920465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant treatment of keloid scars: electrons or brachytherapy?].
    Yossi S; Krhili S; Mesgouez-Nebout N; Vinchon-Petit S; Jadaud E; Tuchais C; Cellier P; Autret D; Rio E; Fernandez L; Poirier AL; Mahé MA; Paumier A
    Cancer Radiother; 2013 Feb; 17(1):21-5. PubMed ID: 23332126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the treatment of keloid scars still a challenge in 2006?
    De Lorenzi F; Tielemans HJ; van der Hulst RR; Rhemrev R; Nieman FH; Lutgens LC; Boeckx WD
    Ann Plast Surg; 2007 Feb; 58(2):186-92. PubMed ID: 17245147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal High-Dose-Rate Brachytherapy Fractionation Scheme After Keloid Excision: A Retrospective Multicenter Comparison of Recurrence Rates and Complications.
    Bijlard E; Verduijn GM; Harmeling JX; Dehnad H; Niessen FB; Meijer OWM; Mureau MAM
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):679-686. PubMed ID: 29249529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.